Navigation Links
Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction
Date:12/11/2007

- Automated Benchtop Workstation Aids Mass Spectrometer Analysis -

HOPKINTON, Mass., Dec. 11 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced the availability of the Zephyr SPE Workstation, a benchtop solution designed to automate Solid Phase Extraction (SPE). With features including a 96-well plate format and easy-to-use, SPE-specific software interface, the Zephyr SPE Workstation is designed to increase efficiency and streamline the sample preparation process for mass spectrometer analysis.

Used in various scientific applications, such as isolating chemical analytes in biological samples, SPE is a fundamental process for practical applications including drugs of abuse screening, drug metabolism testing, contract research screening and forensic sample screening. Amid the rapid growth of the mass spectrometer market, the Zephyr SPE Workstation's customized features meet industry demand for sample preparation tools that improve throughput and streamline processes.

"As the mass spectrometry market continues to grow, increased demand has been placed on sample preparation tools. Researchers need reliable systems that improve throughput and streamline processes," said John Siira, Market Segment Manager, Caliper Life Sciences. "The Zephyr SPE Workstation is Caliper's solution for higher throughput solid phase extraction."

The Zephyr SPE Workstation can process 96 samples simultaneously, amplifying sample preparation throughput. Cost-efficient with a convenient benchtop design, the workstation also offers clog detection, which enables operators to reliably process all samples.

The Zephyr SPE Workstation, US$65K for a complete solution, is currently available for purchase. Additional information can be found online at http://www.CaliperLS.com.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of leading-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.

Caliper is a registered trademark and Zephyr is a trademark of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
2. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
3. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
4. Caliper Life Sciences Presentation at UBS Global Life Sciences Conference to be Webcast
5. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
6. Caliper Life Sciences to Participate in Deutsche Banks Healthcare Technology Industry Day
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
9. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... ... , ... A number of new instruments have recently emerged to accommodate different ... Protein and Cell Analysis Education Webinar Series , will focus on advances in the ... future applications. , Many flow cytometers have unique capabilities and the Attune NxT ...
(Date:4/19/2017)... ... April 19, 2017 , ... Nobilis Therapeutics Announces Completion of ... Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial , Nobilis ... clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in the treatment of ...
(Date:4/19/2017)... ... April 19, 2017 , ... As part of the ... to novices as well as experienced users, attendees will gain a better understanding ... tests. , Hemostasis testing quality is determined by preanalytical variables which encompass ...
(Date:4/19/2017)... WESTMINSTER, Colo. , April 19, 2017 ... specialty finance firm that provides senior debt to ... the closing of a $20 million senior secured ... orthobiologics company engaged in the development and commercialization ... of orthopedic injuries. Cerapedics, lead product, ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
Breaking Biology News(10 mins):